Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Plos Computational Biology|April 22, 2016
CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA SequencingEric Talevich, A Hunter Shain, Thomas Botton, et al.Plos One|November 10, 2010
Rac1 dynamics in the human opportunistic fungal pathogen Candida albicansRomain Vauchelles, Danièle Stalder, Thomas Botton, et al.Chemmedchem|December 21, 2023
Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring OpeningOleksandr Grytsai, Nedra Hamouda-Tekaya, Thomas Botton, et al.The Oncologist|April 7, 2018
Hybrid Capture-Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in <i>BRCA1-</i>Mutant Cholangiocarcinoma Harboring a Novel <i>YWHAZ-BRAF</i> FusionHuat C Lim, Meagan Montesion, Thomas Botton, et al.The Journal of Investigative Dermatology|January 30, 2009
In vitro and in vivo anti-melanoma effects of ciglitazoneThomas Botton, Alexandre Puissant, Philippe Bahadoran, et al.The Journal of Pathology|August 2, 2016
NTRK3 kinase fusions in Spitz tumoursIwei Yeh, Meng Kian Tee, Thomas Botton, et al.Cell Death & Disease|January 12, 2021
Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapiesEmilie Jaune, Elisa Cavazza, Cyril Ronco, et al.Pigment Cell & Melanoma Research|July 30, 2013
Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapyThomas Botton, Iwei Yeh, Tyrrell Nelson, et al.Cell Reports|October 17, 2019
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug ResponsesThomas Botton, Eric Talevich, Vivek Kumar Mishra, et al.Nature Communications|May 28, 2015
Activating MET kinase rearrangements in melanoma and Spitz tumoursIwei Yeh, Thomas Botton, Eric Talevich, et al.Pageof 2